Cargando…

Expression and prognosis analysis of TET family in acute myeloid leukemia

TET family members (TETs) encode proteins that represent crucial factors in the active DNA demethylation pathway. Evidence has proved that TET2 mutation is associated with leukemogenesis, drug response, and prognosis in acute myeloid leukemia (AML). However, few studies revealed the TETs expression...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Tingjuan, Zhao, Yangli, Zhao, Yangjing, Zhou, Jingdong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7138570/ https://www.ncbi.nlm.nih.gov/pubmed/32209730 http://dx.doi.org/10.18632/aging.102928

Ejemplares similares

Comprehensive analysis of ID genes reveals the clinical and prognostic value of ID3 expression in acute myeloid leukemia using bioinformatics identification and experimental validation
por: Zhao, Qi, et al.
Publicado: (2022)

Expression and prognosis analysis of DNMT family in acute myeloid leukemia
por: Zhang, Ting-Juan, et al.
Publicado: (2020)

Expression characteristic of 4Ig B7-H3 and 2Ig B7-H3 in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

Expression and prognosis of the B7 family in acute myeloid leukemia
por: Zhang, Wei, et al.
Publicado: (2021)

The prognostic role of C-KIT, TET1 and TET2 gene expression in Acute Myeloid Leukemia
por: Nabil, Reem, et al.
Publicado: (2022)

Expression and prognosis analyses of CASP1 in acute myeloid leukemia
por: Liu, Jing, et al.
Publicado: (2021)

Comprehensive analysis of PTPN family expression and prognosis in acute myeloid leukemia
por: Liu, Yong, et al.
Publicado: (2023)

Comprehensively analyze the expression and prognostic role for ten-eleven translocations (TETs) in acute myeloid leukemia
por: Huang, Yan, et al.
Publicado: (2020)

High Expression of TET1 Predicts Poor Survival in Cytogenetically Normal Acute Myeloid Leukemia From Two Cohorts
por: Wang, Jinghan, et al.
Publicado: (2018)

High expression of DOCK2 indicates good prognosis in acute myeloid leukemia
por: Hu, Ning, et al.
Publicado: (2019)

TET2 and MEG3 promoter methylation is associated with acute myeloid leukemia in a Hainan population
por: Yao, Hongxia, et al.
Publicado: (2017)

Analysis of TET2 and EZH2 gene functions in chromosome instability in acute myeloid leukemia
por: Wang, Jingyi, et al.
Publicado: (2020)

Pseudogene BMI1P1 expression as a novel predictor for acute myeloid leukemia development and prognosis
por: Zhou, Ling-Yu, et al.
Publicado: (2016)

The Biological and Clinical Consequences of RNA Splicing Factor U2AF1 Mutation in Myeloid Malignancies
por: Zhao, Yangjing, et al.
Publicado: (2022)

The prognostic impact of tet oncogene family member 2 mutations in patients with acute myeloid leukemia: a systematic-review and meta-analysis
por: Wang, Ruiqi, et al.
Publicado: (2019)

High Expression of VAV Gene Family Predicts Poor Prognosis of Acute Myeloid Leukemia
por: Mu, Dan, et al.
Publicado: (2021)

Biallelic TET2 mutations confer sensitivity to 5′-azacitidine in acute myeloid leukemia
por: Stölzel, Friedrich, et al.
Publicado: (2023)

TET2 lesions enhance the aggressiveness of CEBPA-mutant acute myeloid leukemia by rebalancing GATA2 expression
por: Heyes, Elizabeth, et al.
Publicado: (2023)

Upregulation of miR-99a is associated with poor prognosis of acute myeloid leukemia and promotes myeloid leukemia cell expansion
por: Si, Xiaohui, et al.
Publicado: (2016)

Prognosis and regulation of an adenylyl cyclase network in acute myeloid leukemia
por: Chen, Si-Liang, et al.
Publicado: (2020)

Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2017)

TET2 mutations in acute myeloid leukemia: a comprehensive study in patients of Sindh, Pakistan
por: Shaikh, Abdul Rehman Khalil, et al.
Publicado: (2021)

High bone marrow ID2 expression predicts poor chemotherapy response and prognosis in acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

KRAS overexpression independent of RAS mutations confers an adverse prognosis in cytogenetically normal acute myeloid leukemia
por: Zhou, Jing-Dong, et al.
Publicado: (2017)

High Expression Levels of ACTN1 and ACTN3 Indicate Unfavorable Prognosis in Acute Myeloid Leukemia
por: Yang, Xinrui, et al.
Publicado: (2019)

Transposable Element Expression in Acute Myeloid Leukemia Transcriptome and Prognosis
por: Colombo, Anthony R., et al.
Publicado: (2018)

Reduced expression of chemerin is associated with poor clinical outcome in acute myeloid leukemia
por: Zhang, Jing, et al.
Publicado: (2017)

SALL1 expression in acute myeloid leukemia
por: Salman, Huda, et al.
Publicado: (2017)

High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017)

Increased MCL-1 expression predicts poor prognosis and disease recurrence in acute myeloid leukemia
por: Li, Xi-xi, et al.
Publicado: (2019)

High expression of CPNE3 predicts adverse prognosis in acute myeloid leukemia
por: Fu, Lin, et al.
Publicado: (2017)

Karyotype complexity and prognosis in acute myeloid leukemia
por: Stölzel, F, et al.
Publicado: (2016)

Cytogenetics’ impact on the prognosis of acute myeloid leukemia
por: Gupta, Monika, et al.
Publicado: (2019)

Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis
por: Mosrati, Mohamed Ali, et al.
Publicado: (2015)

Enhanced MCM5 Level Predicts Bad Prognosis in Acute Myeloid Leukemia
por: Wang, Shuming, et al.
Publicado: (2022)

Low expression of ACLY associates with favorable prognosis in acute myeloid leukemia
por: Wang, Jinghan, et al.
Publicado: (2019)

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia
por: Li, Guilan, et al.
Publicado: (2020)

Prognostic significance of Spinster homolog gene family in acute myeloid leukemia
por: Huang, Wenhui, et al.
Publicado: (2020)

Author Correction: Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia
por: Jiang, Xi, et al.
Publicado: (2018)

Clinical Implication of DNMT3A and TET2 Genes Mutations in Cytogenetically Normal Acute Myeloid Leukemia
por: Aref, Salah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hqcjh2lafps5d4ffo78adhqa4s